...continues to be the leading cause of blindness in people over 65 years of age, and in the United States alone, this population age range is expected to reach 70 million by the year 2050. It is estimated that up to 20% of those individuals older than 65 is at risk for developing AMD and increases to 37% by age 75. Read more

1. About IRRF
   

2. The IRRF Board of Directors
   

3. In Memoriam...
   

4. Grants and Funding
   

5. The Kelman Scholar Award
   

6. The Callahan Scholar Award
   

7. The Loris and David Rich Award
   

8. Latest News in AMD Research
   

9. Current Research Activities

IRRF-Supported Scientist Receives Title of Privatdozent

New Research Reveals Unexpected Biological Pathway in Glaucoma

Study is first to pinpoint the precise anatomical location where vision loss appears to occur in glaucoma.

Mark H. Ellisman, MA, PhD, Director of the Center for Research in Biological Systems at the University of California San Diego, and Nicholas Marsh-Armstrong, PhD, Assistant Professor at the Johns Hopkins University School of Medicine at Kennedy Krieger submitted a proposal that was subsequently approved for funding. The IRRF funds, combined with those of the National Eye Institute of the National Institutes of Health, became additional funding for a study principally supported by the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation.

Read more

SPOTLIGHT ON RESEARCH

Lasker/IRRF Investigator Exchange Funds Awarded

Astrocytes and Glaucomatous Neurodegeneration

In 2008, the Initiative for Innovation in Vision Science, established by the Albert and Mary Lasker Foundation and the International Retinal Research Foundation, began its mission to identify knowledge gaps in vision research and to apply innovative solutions to develop and promote new clinical treatments of ocular diseases. In 2009, the Initiative convened two workshops in Woods Hole, MA with experts in diseases of the retina and glaucoma along with bench and clinical scientists from other complimentary fields. These combined skills and expertise resulted in the identification and refinement of the main unsolved questions, as well as important areas for further glaucoma research, which may now be experimentally addressed using modern techniques.

Read more

Zeeshan Ahmed Cheema, MD Named the 2011 Alston Callahan, MD Visiting Scholar

Foundation News:

The IRRF Invests in

UAB’s Future

Vitreous IGFBP-3 Effects on Müller Cell Proliferation and Tractional Force Generation

JUNE 1 DEADLINE

FOR SUBMISSION OF GRANT PROPOSALS

Go to Guidelines/Application

Network deficiency exacerbates impairment in a mouse model of retinal degeneration